Insider Transactions in Q1 2024 at Moderna, Inc. (MRNA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 27
2024
|
Afeyan Noubar |
SELL
Open market or private sale
|
Direct |
15,000
-0.12%
|
$1,620,000
$108.39 P/Share
|
|
Mar 20
2024
|
Afeyan Noubar |
SELL
Open market or private sale
|
Direct |
15,000
-0.24%
|
$1,530,000
$102.13 P/Share
|
|
Mar 15
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.99%
|
$1,545,000
$103.17 P/Share
|
|
Mar 13
2024
|
Afeyan Noubar |
SELL
Open market or private sale
|
Direct |
15,000
-0.1%
|
$1,635,000
$109.6 P/Share
|
|
Mar 08
2024
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
544
-5.54%
|
$53,856
$99.05 P/Share
|
|
Mar 07
2024
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,138
+10.39%
|
-
|
|
Mar 04
2024
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
117
-1.33%
|
$10,998
$94.34 P/Share
|
|
Mar 04
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
309
-0.02%
|
$29,046
$94.34 P/Share
|
|
Mar 01
2024
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
233
+2.58%
|
-
|
|
Mar 01
2024
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
652
+0.04%
|
-
|
|
Feb 29
2024
|
James M Mock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
647
-13.08%
|
$60,818
$94.57 P/Share
|
|
Feb 29
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
2,388
-0.16%
|
$224,472
$94.57 P/Share
|
|
Feb 29
2024
|
Shannon Thyme Klinger Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
670
-7.26%
|
$62,980
$94.57 P/Share
|
|
Feb 28
2024
|
James M Mock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,315
+21.0%
|
-
|
|
Feb 28
2024
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
4,853
+0.16%
|
-
|
|
Feb 28
2024
|
Shannon Thyme Klinger Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,315
+12.47%
|
-
|
|
Feb 22
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.98%
|
$1,500,000
$100.0 P/Share
|
|
Feb 16
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,542
-0.69%
|
$927,696
$88.88 P/Share
|
|
Feb 16
2024
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,351
-0.48%
|
$2,318,888
$88.88 P/Share
|
|
Feb 14
2024
|
Stephen Hoge President |
BUY
Grant, award, or other acquisition
|
Direct |
22,694
+1.45%
|
-
|
|
Feb 14
2024
|
Stephane Bancel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,736
+1.02%
|
-
|
|
Feb 12
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
304
-0.02%
|
$26,144
$86.23 P/Share
|
|
Feb 09
2024
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
522
+0.03%
|
-
|
|
Jan 16
2024
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
15,000
-0.98%
|
$1,545,000
$103.9 P/Share
|
|
Jan 08
2024
|
James M Mock Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
772
-17.53%
|
$84,148
$109.75 P/Share
|
|
Jan 05
2024
|
James M Mock Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,452
+24.8%
|
-
|